Cargando…

Genetic anticipation in Swedish Lynch syndrome families

Among hereditary colorectal cancer predisposing syndromes, Lynch syndrome (LS) caused by mutations in DNA mismatch repair genes MLH1, MSH2, MSH6 or PMS2 is the most common. Patients with LS have an increased risk of early onset colon and endometrial cancer, but also other tumors that generally have...

Descripción completa

Detalles Bibliográficos
Autores principales: von Salomé, Jenny, Boonstra, Philip S., Karimi, Masoud, Silander, Gustav, Stenmark-Askmalm, Marie, Gebre-Medhin, Samuel, Aravidis, Christos, Nilbert, Mef, Lindblom, Annika, Lagerstedt-Robinson, Kristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681299/
https://www.ncbi.nlm.nih.gov/pubmed/29088233
http://dx.doi.org/10.1371/journal.pgen.1007012
_version_ 1783277892790124544
author von Salomé, Jenny
Boonstra, Philip S.
Karimi, Masoud
Silander, Gustav
Stenmark-Askmalm, Marie
Gebre-Medhin, Samuel
Aravidis, Christos
Nilbert, Mef
Lindblom, Annika
Lagerstedt-Robinson, Kristina
author_facet von Salomé, Jenny
Boonstra, Philip S.
Karimi, Masoud
Silander, Gustav
Stenmark-Askmalm, Marie
Gebre-Medhin, Samuel
Aravidis, Christos
Nilbert, Mef
Lindblom, Annika
Lagerstedt-Robinson, Kristina
author_sort von Salomé, Jenny
collection PubMed
description Among hereditary colorectal cancer predisposing syndromes, Lynch syndrome (LS) caused by mutations in DNA mismatch repair genes MLH1, MSH2, MSH6 or PMS2 is the most common. Patients with LS have an increased risk of early onset colon and endometrial cancer, but also other tumors that generally have an earlier onset compared to the general population. However, age at first primary cancer varies within families and genetic anticipation, i.e. decreasing age at onset in successive generations, has been suggested in LS. Anticipation is a well-known phenomenon in e.g neurodegenerative diseases and several reports have studied anticipation in heritable cancer. The purpose of this study is to determine whether anticipation can be shown in a nationwide cohort of Swedish LS families referred to the regional departments of clinical genetics in Lund, Stockholm, Linköping, Uppsala and Umeå between the years 1990–2013. We analyzed a homogenous group of mutation carriers, utilizing information from both affected and non-affected family members. In total, 239 families with a mismatch repair gene mutation (96 MLH1 families, 90 MSH2 families including one family with an EPCAM–MSH2 deletion, 39 MSH6 families, 12 PMS2 families, and 2 MLH1+PMS2 families) comprising 1028 at-risk carriers were identified among the Swedish LS families, of which 1003 mutation carriers had available follow-up information and could be included in the study. Using a normal random effects model (NREM) we estimate a 2.1 year decrease in age of diagnosis per generation. An alternative analysis using a mixed-effects Cox proportional hazards model (COX-R) estimates a hazard ratio of exp(0.171), or about 1.19, for age of diagnosis between consecutive generations. LS-associated gene-specific anticipation effects are evident for MSH2 (2.6 years/generation for NREM and hazard ratio of 1.33 for COX-R) and PMS2 (7.3 years/generation and hazard ratio of 1.86). The estimated anticipation effects for MLH1 and MSH6 are smaller.
format Online
Article
Text
id pubmed-5681299
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-56812992017-11-18 Genetic anticipation in Swedish Lynch syndrome families von Salomé, Jenny Boonstra, Philip S. Karimi, Masoud Silander, Gustav Stenmark-Askmalm, Marie Gebre-Medhin, Samuel Aravidis, Christos Nilbert, Mef Lindblom, Annika Lagerstedt-Robinson, Kristina PLoS Genet Research Article Among hereditary colorectal cancer predisposing syndromes, Lynch syndrome (LS) caused by mutations in DNA mismatch repair genes MLH1, MSH2, MSH6 or PMS2 is the most common. Patients with LS have an increased risk of early onset colon and endometrial cancer, but also other tumors that generally have an earlier onset compared to the general population. However, age at first primary cancer varies within families and genetic anticipation, i.e. decreasing age at onset in successive generations, has been suggested in LS. Anticipation is a well-known phenomenon in e.g neurodegenerative diseases and several reports have studied anticipation in heritable cancer. The purpose of this study is to determine whether anticipation can be shown in a nationwide cohort of Swedish LS families referred to the regional departments of clinical genetics in Lund, Stockholm, Linköping, Uppsala and Umeå between the years 1990–2013. We analyzed a homogenous group of mutation carriers, utilizing information from both affected and non-affected family members. In total, 239 families with a mismatch repair gene mutation (96 MLH1 families, 90 MSH2 families including one family with an EPCAM–MSH2 deletion, 39 MSH6 families, 12 PMS2 families, and 2 MLH1+PMS2 families) comprising 1028 at-risk carriers were identified among the Swedish LS families, of which 1003 mutation carriers had available follow-up information and could be included in the study. Using a normal random effects model (NREM) we estimate a 2.1 year decrease in age of diagnosis per generation. An alternative analysis using a mixed-effects Cox proportional hazards model (COX-R) estimates a hazard ratio of exp(0.171), or about 1.19, for age of diagnosis between consecutive generations. LS-associated gene-specific anticipation effects are evident for MSH2 (2.6 years/generation for NREM and hazard ratio of 1.33 for COX-R) and PMS2 (7.3 years/generation and hazard ratio of 1.86). The estimated anticipation effects for MLH1 and MSH6 are smaller. Public Library of Science 2017-10-31 /pmc/articles/PMC5681299/ /pubmed/29088233 http://dx.doi.org/10.1371/journal.pgen.1007012 Text en © 2017 von Salomé et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
von Salomé, Jenny
Boonstra, Philip S.
Karimi, Masoud
Silander, Gustav
Stenmark-Askmalm, Marie
Gebre-Medhin, Samuel
Aravidis, Christos
Nilbert, Mef
Lindblom, Annika
Lagerstedt-Robinson, Kristina
Genetic anticipation in Swedish Lynch syndrome families
title Genetic anticipation in Swedish Lynch syndrome families
title_full Genetic anticipation in Swedish Lynch syndrome families
title_fullStr Genetic anticipation in Swedish Lynch syndrome families
title_full_unstemmed Genetic anticipation in Swedish Lynch syndrome families
title_short Genetic anticipation in Swedish Lynch syndrome families
title_sort genetic anticipation in swedish lynch syndrome families
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681299/
https://www.ncbi.nlm.nih.gov/pubmed/29088233
http://dx.doi.org/10.1371/journal.pgen.1007012
work_keys_str_mv AT vonsalomejenny geneticanticipationinswedishlynchsyndromefamilies
AT boonstraphilips geneticanticipationinswedishlynchsyndromefamilies
AT karimimasoud geneticanticipationinswedishlynchsyndromefamilies
AT silandergustav geneticanticipationinswedishlynchsyndromefamilies
AT stenmarkaskmalmmarie geneticanticipationinswedishlynchsyndromefamilies
AT gebremedhinsamuel geneticanticipationinswedishlynchsyndromefamilies
AT aravidischristos geneticanticipationinswedishlynchsyndromefamilies
AT nilbertmef geneticanticipationinswedishlynchsyndromefamilies
AT lindblomannika geneticanticipationinswedishlynchsyndromefamilies
AT lagerstedtrobinsonkristina geneticanticipationinswedishlynchsyndromefamilies